Meghmani Organics Ltd (NSE: MOL, BSE: 543331) is a Ahmedabad, Gujarat-based company in the Crop Protection Chemicals industry. With a market capitalisation of ₹1,514 Cr, it ranks #1,380 by market cap among the 6,137 Indian listed companies on FinBizNet, and #15 of 45 in Crop Protection Chemicals. At ₹51.85 (as of 25 Oct 2026), the share price is 37.3% below its 52-week high of ₹82.68 and 42.1% above its 52-week low of ₹36.50. The share price is down 35.6% over one year and down 4.8% over three months.
| Current Price | ₹51.85 |
|---|---|
| Market Cap | ₹1,514 Cr |
| NSE Symbol | MOL |
| BSE Code | 543331 |
| Sector | Materials > Chemicals > Fertilizers & Agri Chemicals |
| Sub-Industry | Fertilizers and Agricultural Chemicals > Crop Protection Chemicals |
| P/E Ratio | 50 |
| Return on Equity | 1.88% |
| Return on Assets | 1.27% |
| 52-Week Range | ₹36.50 – ₹82.68 |
| 1-Year Price Change | -35.6% |
| 3-Month Price Change | -4.8% |
| Beta (1Y) | 1.31 |
| Dividend Yield | 0.00% |
| Headquarters | Ahmedabad, Gujarat |
| Website | meghmani.com |
| Revenue | ₹543 Cr |
|---|---|
| Net Profit | ₹48 Cr |
| Net Margin | 8.9% |
| EPS (Basic) | ₹1.90 |
| Basis | consolidated |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Meghmani Organics Limited manufactures and sells pigments and agrochemicals in India and internationally. The company offers green and blue pigments, which are used in printing inks, paints and coatings, and plastics. It also offers agrochemical products comprising insecticides, which include acetamiprid, alphacypermethrin, bifenthrin, betacyfluthrin, cyfluthrin, cypermethrin, deltamethrin, dinotefuran, ethiprole, fipronil, flonicamid, flubendiamide, lambdacyhalothrin, permethrin, profenofos, pymetrozine, pyriproxyfen, and spiromesifen. in addition, the company provides herbicides, such as 2,4 D acid, amine, esters and triclopyr; intermediates, including cypermethric acid chloride, lambdacyhalothric acid (TFP Acid), pyrazole, high cis/trans CMAC, meta phenoxy benzaldehyde, and spiromesifen acid. Further, it offers technical and formulations that are used in crop protection, veterinary health, household pest control, and public health initiatives. Additionally, the company offers anatas
1. Pigments-This segment engages in the manufacture and marketing of phthalocynine green 7, copper phthalocynine blue, alpha blue, and beta blue. 2. Agro Chemicals-This segment engages in the manufacture and marketing of technical, intermediates, and formulation of crop protection chemicals. 3. Others/Unallocated-0 4. Inter-Segment Sales-0
1. Pigments-24.4% 2. Agro Chemicals-75% 3. Others-3.1%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| United Phosphorus Ltd. (UPL) | ₹45,036 Cr | 23.7 | 5.61% | ₹10,181 Cr | -25.2% |
| PI Industries Ltd | ₹33,205 Cr | 24.8 | 12.35% | ₹1,702 Cr | -42.2% |
| Sumitomo Chemicals India Ltd | ₹20,203 Cr | 36 | 17.24% | ₹1,063 Cr | -30.3% |
| Bayer Cropscience Ltd | ₹16,360 Cr | 23.2 | 23.70% | ₹1,835 Cr | -33.8% |
| Eid Parry India Ltd | ₹12,315 Cr | 21.1 | 9.91% | ₹9,018 Cr | -39.2% |
| Sharda Cropchem Ltd | ₹6,544 Cr | 9.2 | 24.16% | ₹1,074 Cr | -22.0% |
| Rallis India Ltd. | ₹3,985 Cr | 21.6 | 9.32% | ₹858 Cr | -31.6% |
| Dhanuka Agritech Ltd | ₹3,867 Cr | 13.6 | 18.62% | ₹462 Cr | -40.1% |
| Meghmani Organics Ltd | ₹1,514 Cr | 50 | 1.88% | ₹543 Cr | -35.6% |
Listed by market capitalisation. Ratios are shown for context only.
Meghmani Organics Ltd is trading at ₹51.85, with a market capitalisation of ₹1,514 Cr.
Meghmani Organics Ltd operates in the Materials > Chemicals > Fertilizers & Agri Chemicals space (Fertilizers and Agricultural Chemicals > Crop Protection Chemicals).
Meghmani Organics Ltd has a P/E of 50 and a return on equity of 1.88%.
Meghmani Organics Ltd is listed on the NSE under the symbol MOL and on the BSE under the scrip code 543331.
Meghmani Organics Ltd's share price is down 35.6% over one year and down 4.8% over three months. Its 52-week range is ₹36.50 to ₹82.68.
In Q1 FY27, Meghmani Organics Ltd reported revenue of ₹543 Cr and net profit of ₹48 Cr, with basic EPS of ₹1.9 (consolidated, parsed from the company's exchange filing).
Data as of 25 Oct 2026. Descriptive market data only — not investment advice.